Mitchell Ron B, Kelly James
Division of Pediatric Otolaryngology, Cardinal Glennon Children's Medical Center, Department of Otolaryngology, Head and Neck Surgery, St. Louis University School of Medicine, St. Louis, MO 63104, USA.
ORL J Otorhinolaryngol Relat Spec. 2007;69(6):345-8. doi: 10.1159/000108366. Epub 2007 Nov 23.
To summarize current knowledge of the outcome of adenotonsillectomy (T&A) for the treatment of sleep-disordered breathing (SDB) in children.
The success rate of T&A for SDB as measured on the basis of objective criteria using polysomnography ranges from 79 to 92%. Dramatic improvements in quality of life after T&A for SDB have been shown in a number of studies and these improvements are maintained up to 2 years after surgery. Significant improvements that are maintained in the long term are also seen in behavioral and neurocognitive parameters following T&A for SDB. Not surprisingly, total health care costs are reduced by one third following T&A mostly because of a reduction in upper respiratory tract infections.
T&A is associated with improvements in polysomnography, behavior and quality of life in children with SDB. Improved health in these children leads to a reduction in health care utilization.
总结目前关于腺样体扁桃体切除术（T&A）治疗儿童睡眠呼吸障碍（SDB）疗效的知识。
根据多导睡眠图客观标准衡量，T&A治疗SDB的成功率在79%至92%之间。多项研究表明，T&A治疗SDB后生活质量有显著改善，且这些改善在术后长达2年都能维持。T&A治疗SDB后，行为和神经认知参数也有长期维持的显著改善。不出所料，T&A后总体医疗保健成本降低了三分之一，主要是因为上呼吸道感染减少。
T&A与SDB患儿多导睡眠图、行为和生活质量的改善相关。这些患儿健康状况的改善导致医疗保健利用率降低。
